Experts Discuss How Pharmacists Can Help Fight Opioid Addiction
December 2nd 2021Jaime Bridges, opioid outreach coordinator at Orlando Health Orlando Regional Medical Center, and Kris Smith, PharmD, clinical pharmacy specialist for internal medicine at Orlando Health Orlando Regional Medical Center discuss how COVID-19 has affected the opioid crisis and what opioid-free pain management options are available as alternatives.
Read More
FDA Approves Daratumumab Triplet Combo for Relapsed/Refractory Multiple Myeloma
December 2nd 2021The combination of daratumumab with hyaluronidase (Darzalex Faspro), hyaluronidase-fihj, carfilzomib (Kyprolis), and dexamethasone is indicated for the treatment of adult patients with relapsed/refractory multiple myeloma who have received 1 to 3 prior lines of therapy.
Read More
Certain Patients With Heart Failure May Benefit From Stem Cell Therapy
December 1st 2021Stem cell therapy was associated with a reduction of the number of heart attacks, strokes, and death among people with chronic, high-risk, NYHA class 2 or 3 heart failure with reduced ejection fraction (HFrEF), according to a study presented at the American Heart Association’s Scientific Sessions 2021.
Read More